| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Director
2 companies
Henderson John T is a Director at CYTK, with reported holdings spanning 2 companies. Recent filings cover 5 purchases and 27 sales. Those positions are worth an estimated $5.0M at current prices.
Our model assigns Henderson John T a middling insider score of 65/100, based on 11 past trades. Over a 12-month horizon, 50.0% of those trades were profitable, with an average 12-month return of -5.8%.
Henderson John T's largest disclosed position is in CYTK as Director, worth about $5.0M. The recent filings there lean toward selling, a net 98,359 shares.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| May 5, 2026 | CYTK Cytokinetics, Incorporated | Director | Sale+OE10b5-1 | 20,000 | $75.97 | $1,519,400.00 | -21.0% | -0.8% | - | |
| Dec 2, 2025 | CYTK Cytokinetics Inc | Director | Sale+OE10b5-1 | 8,750 | $63.90 | $559,125.00 | -10.5% | -3.2% | - | |
| Apr 15, 2025 | CYTK Cytokinetics Inc | Director | Sale+OE10b5-1 | 3,190 | $38.66 | $123,325.40 | -4.6% | +0.1% | +68.6% | |
| Dec 11, 2024 | CYTK Cytokinetics Inc | Director | Sale+OE10b5-1 | 1,780 | $50.42 | $89,747.60 | -4.4% | -12.4% | +19.9% | |
| Apr 25, 2024 | CYTK Cytokinetics Inc | Director | Sell10b5-1 | 10,562 | $64.54 | $681,671.48 | -24.8% | -12.3% | -37.6% | |
| Feb 14, 2024 | CYTK Cytokinetics Inc | Director | Sale+OE10b5-1 | 5,000 | $76.48 | $382,400.00 | -10.5% | -22.4% | -45.6% | |
| Jan 12, 2024 | CYTK Cytokinetics Inc | Director | Sale+OE10b5-1 | 5,000 | $85.14 | $425,700.00 | -10.5% | -14.5% | -45.5% | |
| Dec 18, 2023 | CYTK Cytokinetics Inc | Director | Sale+OE10b5-1 | 2,458 | $36.34 | $89,323.72 | -5.5% | +76.6% | +32.4% | |
| May 15, 2023 | CYTK Cytokinetics Inc | Director | Sale+OE10b5-1 | 4,166 | $37.77 | $157,349.82 | -14.1% | -17.6% | +52.4% | |
| Sep 12, 2022 | CYTK Cytokinetics Inc | Director | Sale+OE | 21,759 | $54.94 | $1,195,548.22 | -47.5% | -29.6% | -35.6% |